{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-002359","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.842930+00:00","generated_at":"2026-05-16T11:15:35.485527+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"low","headline":"60 Degrees Pharmaceuticals provides investor presentation via RedChip webinar; no specific details disclosed","bullets":["Company made investor presentation available on January 8, 2026, in connection with RedChip webinar.","Presentation covers updated clinical development timelines and regulatory strategy (no details disclosed).","Filing includes standard forward-looking statement disclaimer; no financial guidance provided.","Presentation exhibit (Ex. 99.1) contains only cover page and disclaimer, not slide content."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-002359","json":"https://secwatch.observer/filing/0001213900-26-002359.json","markdown":"https://secwatch.observer/filing/0001213900-26-002359.md","text":"https://secwatch.observer/filing/0001213900-26-002359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/0001213900-26-002359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390026002359/ea0272213-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:15:35.485527+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}